please create a reply for the following discussion of another student.

Other student discussion: 

To ensure stakeholder buy-in for the capstone project proposal, it is crucial to present a comprehensive and detailed plan that addresses their concerns and highlights the potential benefits of the educational adherence program. The proposal should begin with a clear and concise introduction, providing an overview of the project, including the PICOT question and its significance in addressing medication adherence in elderly patients with chronic conditions. The problem statement should articulate the issue of medication non-adherence in this specific population, emphasizing the negative consequences such as increased hospital re-admissions, poor health outcomes, and higher healthcare costs. A thorough literature review should be included, presenting relevant studies that support the need for an educational adherence program and demonstrate the effectiveness of similar interventions in improving medication adherence among elderly patients with chronic conditions (Boaz et al., 2018). The objectives of the proposed program should be clearly stated, aligning them with the overall goals of the stakeholders, such as improving patient satisfaction or reducing healthcare costs. A detailed description of the educational adherence program, including its content, format, and delivery methods, should be provided, highlighting the involvement of nurses as program leaders and emphasizing their expertise in providing personalized care and support to patients. An implementation plan should outline the step-by-step process for integrating the program into standard care in hospitals, including details on nurse training, patient identification and enrollment, and integration into existing workflows (Petkovic et al., 2020). The proposal should also describe the methods that will be used to evaluate the program’s effectiveness, such as pre- and post-intervention surveys, medication adherence measurements, and patient satisfaction surveys. The potential positive outcomes, such as improved medication adherence rates and reduced healthcare utilization, should be highlighted. The involvement of stakeholders, such as hospital administrators, healthcare providers, and patients, should be clearly outlined, emphasizing the benefits they can expect from the program, such as improved patient outcomes, reduced costs, and enhanced reputation. A detailed budget should be provided, including the necessary resources for implementing and sustaining the program, and the cost-effectiveness of the program should be demonstrated by comparing potential savings to the required investment. In conclusion, the proposal should summarize the potential benefits of the educational adherence program and emphasize the importance of stakeholder buy-in, encouraging their support and offering opportunities for further discussion and collaboration. By including these detailed elements in the proposal, stakeholders’ concerns can be effectively addressed, the value of the educational adherence program can be demonstrated, and the likelihood of obtaining their buy-in for the capstone project can be increased (Morton et al., 2017).

Reference

Boaz, A., Hanney, S., Borst, R., O’Shea, A., & Kok, M. (2018). How to engage stakeholders in research: design principles to support improvement. Health Research Policy and Systems, 16(1). https://doi.org/10.1186/s12961-018-0337-6

Morton, K. L., Atkin, A. J., Corder, K., Suhrcke, M., Turner, D., & van Sluijs, E. M. F. (2017). Engaging stakeholders and target groups in prioritising a public health intervention: the Creating Active School Environments (CASE) online Delphi study. BMJ Open, 7(1), e013340. https://doi.org/10.1136/bmjopen-2016-013340

Petkovic, J., Riddle, A., Akl, E. A., Khabsa, J., Lytvyn, L., Atwere, P., Campbell, P., Chalkidou, K., Chang, S. M., Crowe, S., Dans, L., Jardali, F. E., Ghersi, D., Graham, I. D., Grant, S., Greer-Smith, R., Guise, J.-M., Hazlewood, G., Jull, J., & Katikireddi, S. V. (2020). Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation. Systematic Reviews, 9(21), 1–11. https://doi.org/10.1186/s13643-020-1272-5